1. Immunotherapies for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: Current and developing strategies
    Josepmaria Argemi et al, 2022, Hepatobiliary Cancers: Translational Advances and Molecular Medicine CrossRef
  2. Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report
    Jing Jiang et al, 2022, Frontiers in Oncology CrossRef
  3. Discordant microsatellite instability findings in two samples from a patient with biliary cancer that responded to pembrolizumab
    Hiroyuki Matsubayashi et al, 2023, Clinical Journal of Gastroenterology CrossRef
  4. Targeted Therapies in Advanced Cholangiocarcinoma
    Michael H. Storandt et al, 2023, Life CrossRef
  5. Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis
    Giorgio Frega et al, 2023, Cells CrossRef
  6. Current and emerging immunotherapeutic approaches for biliary tract cancers
    Zhen-Gang Yuan et al, 2022, Hepatobiliary & Pancreatic Diseases International CrossRef
  7. Microsatellite instability in patients with hepato-biliary-pancreatic malignancies in clinical practice (KHBO 1903)
    Shoji Kubo et al, 2022, International Journal of Clinical Oncology CrossRef
  8. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
    Robin Kate Kelley et al, 2023, The Lancet CrossRef
  9. Clinical characteristics of pancreatic and biliary tract cancers in Lynch syndrome: A retrospective analysis from the Finnish National Lynch Syndrome Research Registry
    Kristina Zalevskaja et al, 2023, Frontiers in Oncology CrossRef